ACADIA PHARMACEUTICALS INC
ACAD · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $3.8B · 798 employees
Business Summary
. 3 Item 1A. Risk Factors . 26 Item 1B. Unresolved Staff Comments. 64 Item 1C. Cybersecurity. 64 Item 2. Properties . 66 Item 3. Legal Proceedings . 66 Item 4. Mine Safety Disclosures . 67 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 68 Item 6. [Reserved] 69 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations. 69 Item 7A. Quantitative and Qualitative Disclosures About Market R...
Latest Stock Quote
ACAD 2026-05-29
$21.66
O:$21.65 H:$21.955 L:$21.58 Vol:1.7M VWAP:$21.7048
origin leaf: b8775ceeef3ba4991c21189a2fafc122064f94594a97eb865515fa2c1272c734
Next Earnings
Q2 FY2026 — expected 2026-08-11
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | ACAD | discussed Regulation | |
| topic_mention | ACAD | discussed Automotive | |
| metric | ACAD total revenue | reported $1.07 Billion | |
| guidance | ACAD | guided Guidance NUPLAZID Net Sales $692 Million | |
| guidance | ACAD | guided FY 2025 GAAP Financial Highlights
FY25 Results FY26 GAAP Guidance NUPLAZID Net Sales $692 Million | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-072519 | EDGAR | 88K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-029253 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0000950170-24-021473 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0000950170-23-004757 | EDGAR | — |
| 2022-03-01 | 2021-12-31 | 0000950170-22-002392 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001564590-21-008372 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001564590-20-006889 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0001564590-19-004596 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001564590-18-003526 | EDGAR | — |
| 2017-02-28 | 2016-12-31 | 0001564590-17-002866 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-267453 | EDGAR | 49K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104295 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066231 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-122513 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092163 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056077 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0000950170-23-058436 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000950170-23-037458 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018927 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021438 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-015642 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0000950170-22-007468 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-05 | 0001193125-26-092213 | EDGAR | 1K words |
| 2026-02-25 | 0001193125-26-071674 | EDGAR | — |
| 2026-01-13 | 0001193125-26-011706 | EDGAR | — |
| 2025-11-05 | 0001193125-25-266959 | EDGAR | — |
| 2025-11-03 | 0001193125-25-262610 | EDGAR | — |
| 2025-08-06 | 0000950170-25-104092 | EDGAR | — |
| 2025-06-10 | 0001193125-25-138452 | EDGAR | — |
| 2025-05-29 | 0001193125-25-130620 | EDGAR | — |
| 2025-05-20 | 0001193125-25-123175 | EDGAR | — |
| 2025-05-07 | 0000950170-25-065672 | EDGAR | — |
274 total filings indexed. 242 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Earnings Transcripts
| Call Date | Quarter | Title |
|---|
| — | | ACAD Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
Sector Peers
Company Identity
| CIK | 0001070494 |
| Ticker | ACAD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.acadia.com |
| Listed | 2004-05-27 |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 9a3dfac3e06e884f15130f6cefe76ab2416a4263ed9654f16163402df7f8ea1c
parent: 0905ed7f7e649f1801f5e7623b56ab98ac6918ce666e3b662c90f4d3509ef3d4
content hash: 304fe39d7133add785fc5c4f74cfa59f3f4441e0672ff0359d6d0fa479b3f7e0
signed: 2026-06-02T19:00:02.995Z
sources: 24 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf